SCHEMBL4430169

SCHEMBL4430169

C[C@H](O)C1Cc2ccccc2N1C(=O)O.O=C1CN1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.43
ACE P12821 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9930255 0.74 NOTUM (0.43) NOTUMACE
SCHEMBL4436087 0.74 NOTUM (0.43) NOTUMACE
SCHEMBL4436088 0.74 NOTUM (0.43) NOTUMACE
SCHEMBL4430164 0.72 MTNR1A (0.46) NOTUMACE
SCHEMBL28221747 0.70 NOTUM (0.51) NOTUMACE
SCHEMBL21700185 0.70 PRKCG (0.45) NOTUMACE
SCHEMBL20462830 0.70 NOTUM (0.75) NOTUM
SCHEMBL13210097 0.70 NOTUM (0.64) NOTUMACE
SCHEMBL11777536 0.69 AADAT (0.39) NOTUMACE
SCHEMBL11777527 0.69 AADAT (0.39) NOTUMACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134721-A1 ANTIMICROBIAL HETEROCYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS Micurx Pharmaceuticals, Inc. (US) 2009-12-23 EP disclosed
WO-2008108988-A1 ANTIMICROBIAL HETEROCYCLIC COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS MICURX PHARMACEUTICALS, INC. (US) 2008-09-12 WO disclosed